51111704 Mitomycin

Definition

UNSPSC 51111704

This classification denotes an alkylating agent, antibiotics, antineoplastic, cross-linking reagent, and nucleic acid synthesis inhibitor with the molecular formula C15H18N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50SG953SK6, chemically known as 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2,3:3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) but generally known as mitomycin, which bears US NIH Compound Identifier 5746. European Medicines Agency schedules Mitomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09006MIG. The term MITOMYCIN is an International Non-Proprietary Name. World Health Organization schedules mitomycin in its Anatomical Therapeutic Chemical (ATC) Classification. MITOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mitomycin under HS 29419000 and SITC 54139. As of Q4 2014, MITOMYCIN remains the US FDA Preferred Term for this commodity. Mitomycin bears US NLM identifiers UMLS ID C0002475 and NCI Concept Code C1820. SMILES: O(C12N(CC3NC13)C1=C(C2COC(=O)N)C(=O)C(=C(C1=O)C)N)C.

Same parent

Under 51111700 · 67

51111703 Daunorubicin citrate Commodity 51111704 Mitomycin You are here 51111707 Deoxycoformycin or pentostatin Commodity 51111716 Rituximab Commodity 51111717 Trastuzumab Commodity 51111725 Acodazole Commodity 51111726 Ambazone Commodity 51111727 Amsacrine Commodity 51111728 Cabazitaxel Commodity 51111729 Arsenic trioxide Commodity 51111730 Azotomycin Commodity 51111731 Bevacizumab Commodity 51111732 Bisantrene Commodity 51111733 Bleomycin Commodity 51111734 Butantrone Commodity 51111735 Cemadotin Commodity 51111736 Cetuximab Commodity 51111737 Crisnatol Commodity 51111738 Datelliptium Commodity 51111739 Etoposide Commodity 51111740 Daunorubicin hydrochloride Commodity 51111741 Demecolcine Commodity 51111742 Eribulin Commodity 51111743 Medorubicin Commodity 51111744 Galarubicin Commodity 51111745 Gemtuzumab Commodity 51111746 Ipilimumab Commodity 51111747 Ixabepilone Commodity 51111748 Ladirubicin Commodity 51111749 Leurubicin Commodity 51111750 Losoxantrone Commodity 51111751 Ortetamine Commodity 51111752 Menogaril Commodity 51111753 Mitoguazone Commodity 51111754 Mitonafide Commodity 51111755 Nogalamycin Commodity 51111756 Ofatumumab Commodity 51111757 Teloxantrone Commodity 51111758 Panitumumab Commodity 51111759 Piroxantrone Commodity 51111760 Pixantrone Commodity 51111761 Ranibizumab Commodity 51111762 Romidepsin Commodity 51111763 Soblidotin Commodity 51111764 Vinepidine Commodity 51111765 Trabectedin Commodity 51111766 Vinblastine Commodity 51111767 Vincristine Commodity 51111768 Vindesine Commodity 51111769 Vinflunine Commodity 51111770 Vinfosiltine Commodity 51111771 Vinleucinol Commodity 51111772 Vinorelbine Commodity 51111773 Vinzolidine Commodity 51111774 Vorinostat Commodity 51111775 Bizelesin Commodity 51111776 Podofilox Commodity 51111777 Salinomycin Commodity 51111778 Alemtuzumab Commodity 51111779 Carfilzomib Commodity 51111780 Durvalumab Commodity 51111781 Olaparib Commodity 51111782 Obinutuzumab Commodity 51111783 Brentuximab vedotin Commodity 51111784 Atezolizumab Commodity 51111785 Pertuzumab Commodity 51111786 Pembrolizumab Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51110000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class